Greater awareness of increased breast and ovarian cancer risk in women with paternal family history could save lives

October 24, 2010

Individuals with an inherited BRCA1 or BRCA2 gene mutation are at increased risk of cancer, particularly of breast and ovarian cancer. Yet despite both men and women being equally likely to pass this genetic susceptibility to their children, a father's family history is not well recognised as a risk factor. As a result, women who might have inherited the mutated gene from their father could be missing out on opportunities for genetic testing and early diagnosis. These are the conclusions of a Comment published Online First in The Lancet Oncology.

About 5% of breast and ovarian cancer cases are the result of an inherited genetic predisposition mostly caused by the BRCA1 or BRCA2 genes. These gene mutations increase the risk of cancers in both men and women, but women in particular face an increased lifetime risk of breast cancer (55󈟃%) and ovarian cancer (20󈞘%). However, men and women with this genetic predisposition have the same risk (50%) of passing it to each of their children.

According to Jeanna McCuaig from the Princess Margaret Hospital, Toronto, Canada and colleagues, most health-care providers know of the increased breast and ovarian cancer risk in women with this gene mutation, but "many remain unaware that these women might have inherited the mutated gene from their father...and might not routinely collect this information from their patients." Moreover, a history of cancer on the father's side may not be as well reported by patients because they do not know it is a risk factor for cancer.

The authors point out that "deficits in knowledge among health-care providers and the general population about the inheritance patterns of BRCA1 and BRCA2 gene mutations could result in missed opportunities for genetic testing and cancer prevention in individuals with a paternal family history."

To further investigate whether such a discrepancy exists, the authors used patient records from their clinic in Toronto, Canada, to compare the number of patients referred with maternal and paternal family history of breast or ovarian cancer. They found that patients with a maternal family history of cancer were 5 times more likely to be referred.

These findings, say the authors, emphasise the importance of health-care providers reviewing and assessing a patient's maternal and paternal family histories equally.

They conclude: "With an increased awareness by health-care providers of the potential paternal transmission of BRCA1 and BRCA2 gene mutations, together with their ability to provide accurate risk assessments, fewer opportunities for cancer prevention will be missed."
-end-
Jeanna McCuaig, Princess Margaret Hospital, Toronto, Canada. T) +1 416 946 2286 E) Jeanna.McCuaig@uhn.on.ca

For full Comment see: http://press.thelancet.com/tlopaternal.pdf

NOTE: THE ABOVE LINK IS FOR JOURNALISTS ONLY; IF YOU WISH TO PROVIDE A LINK TO THE FREE ABSTRACT OF THIS PAPER FOR YOUR READERS, PLEASE USE THE FOLLOWING, WHICH WILL GO LIVE AT THE TIME THE EMBARGO LIFTS:

http://www.thelancet.com/journals/lanonc/article/PII S1470-2045(10)70246-1/abstract

Lancet

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.